Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report

T. J. Wang, C. P. Lin, C. M. Yang, L. L.K. Lin

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)

摘要

The purpose of this article is to report the use of valgancyclovir as maintenance therapy for cytomegalovirus (CMV) retinitis in a lung transplanted patient A 30-year-old woman with underlying pulmonary lymphangioleiomyomatosis received a lung transplant 1 year ago. CMV retinitis developed 4 months later but subsided after intravenous ganciclovir treatment. Unfortunately, the CMV retinitis recurred three times in 1 year while on oral ganciclovir maintenance therapy. To treat the latest relapse, valgancyclovir 900 mg once daily was used as maintenance therapy after intravenous gancyclovir induction. With a 6-month follow-up, the fundoscopic examination revealed old atrophic scar and no active CMV retinits. The patient was able to maintain best-corrected visual acuity of 20/20 in both eyes. In conclusion, Valganciclovir may be used as maintenance therapy in CMV retinitis.

原文英語
頁(從 - 到)2826-2829
頁數4
期刊Transplantation Proceedings
36
發行號9
DOIs
出版狀態已發佈 - 11月 2004
對外發佈

ASJC Scopus subject areas

  • 手術
  • 移植

指紋

深入研究「Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report」主題。共同形成了獨特的指紋。

引用此